Renvilda M 500 Tablet is primarily used to manage type 2 diabetes mellitus, a condition characterised by high blood sugar levels due to insulin resistance. It belongs to the class of medicines known as antidiabetics.
Renvilda M 500 Tablet is prescribed for:
• Managing type 2 diabetes mellitus in adults
• Swallow the tablet whole with a glass of water.
• Take it with meals to minimise gastrointestinal discomfort.
• Follow the dosage and frequency as prescribed by your doctor.
• Always consult your doctor before discontinuing the medicine.
Renvilda M 500 Tablet is taken orally.
Renvilda M 500 Tablet may cause the following side effects:
• Nausea and vomiting
• Diarrhoea
• Stomach pain
• Dizziness
• Headache
Renvilda M 500 Tablet contains the following components, each with a specific mechanism of action:
• Vildagliptin (50 mg): This ingredient inhibits dipeptidyl peptidase-4 (DPP-4), leading to an increased release of insulin from the pancreas and a reduced level of glucagon.
• Metformin (500 mg): This component reduces hepatic glucose production and decreases intestinal absorption of glucose, thereby contributing to lower blood sugar levels.
Renvilda M 500 Tablet is not recommended during pregnancy as it may harm the foetus. Consult your doctor before use.
This medicine is contraindicated during breastfeeding, as its components may pass into breast milk and affect the infant.
Avoid alcohol consumption while taking this medicine as it may exacerbate the risk of lactic acidosis and lower blood glucose levels.
Renvilda M 500 Tablet is not advisable for patients with severe liver conditions due to the risk of metformin-induced lactic acidosis. Discuss any liver concerns with your doctor.
Patients with severe kidney issues should not use this medicine, as it increases the risk of lactic acidosis. Consult your doctor for advice.
This medicine may cause dizziness or drowsiness. Avoid driving or operating machinery until these symptoms are resolved.
Do not take this medicine if you are allergic to metformin, vildagliptin, or any other ingredients in the tablet. Consult your doctor for alternatives.
Renvilda M 500 Tablet is not recommended for individuals under 18 years of age.
Elderly patients should take this medicine under medical supervision due to increased sensitivity to side effects.
Drug-Drug Interactions
• Glucocorticoids: These may reduce the glucose-lowering effect of Renvilda M 500 Tablet.
• Diuretics: Increase the risk of lactic acidosis by accumulating metformin.
• Beta-blockers: May result in an unexpected drop in blood sugar (hypoglycaemia).
• Thyroid hormones: May affect blood glucose control when taken concurrently.
Drug-Food Interactions
• High-fat meals: Fatty foods may reduce the efficacy of Renvilda M 500 Tablet in managing blood sugar levels.
Drug-Disease Interactions
• Type 1 diabetes: Renvilda M 500 Tablet is contraindicated for type 1 diabetes patients.
• Diabetic ketoacidosis: This medicine is contraindicated for those with diabetic ketoacidosis.
• Heart disease: Fluid retention risks may exacerbate heart conditions.
Daily Dosage
• Renvilda M 500 Tablet should be taken as prescribed by your doctor.
Missed Dose
• If you forget to take your dose, take it as soon as you remember, unless it is nearly time for your next dose. Do not double the dose to catch up.
Overdose
• Overdose might result in side effects such as tremors, dizziness, and nausea. If these occur, seek medical attention promptly.
• Store Renvilda M 500 Tablet at room temperature, below 30°C.
• Keep it away from direct sunlight and moisture.
• Ensure the medicine is out of reach of children.
• Verify the expiry date on the packaging before use.
• Maintain a balanced diet low in sugars and rich in fibre for stable blood glucose levels.
• Incorporate regular exercise to aid blood glucose control and reduce cardiovascular risks.
.avif)
%20(1).png)
.webp)